pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

pliant-therapeutics PRESS RELEASE ARCHIVE

Jun 5, 2020

Pliant Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares

Jun 2, 2020

Pliant Therapeutics Announces Pricing of Initial Public Offering

Mar 23, 2020

Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis

Mar 3, 2020

Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases

Jan 8, 2020

Pliant Therapeutics Appoints Gayle Crowell to its Board of Directors

Oct 31, 2019

Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019

Oct 23, 2019

Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases

Oct 15, 2019

Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis

Jun 27, 2019

Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis

Apr 9, 2019

Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis

Mar 28, 2019

Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)

Mar 14, 2019

Pliant Therapeutics Appoints Smital Shah to its Board of Directors

Feb 13, 2019

Pliant Therapeutics to Present at Upcoming Investor Conferences

Jan 3, 2019

Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

Jan 3, 2019

Pliant Therapeutics Appoints Keith Cummings as Chief Financial Officer and Eduard Gorina as Vice President, Clinical Development

Dec 27, 2018

Pliant Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference

Nov 20, 2018

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

Nov 9, 2018

Pliant Therapeutics Presents Preclinical Data in NASH and PSC at The Liver Meeting 2018

Sep 6, 2018

Pliant Therapeutics Announces Research Collaboration with Cleveland Clinic to Develop New Disease Targets for Gastrointestinal Fibrosis

Aug 6, 2018

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis

Jul 16, 2018

Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases

May 22, 2018

Pliant Therapeutics Presents Idiopathic Pulmonary Fibrosis Biomarker Discovery Research at American Thoracic Society 2018 International Conference

May 8, 2018

Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer

Jan 5, 2017

Pliant Therapeutics Appoints Leading Academic Researcher and Industry Veteran Rik Derynck, Ph.D. as Scientific Founder

Aug 30, 2016

Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to Board of Directors

Feb 18, 2016

Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases

Google Analytics Alternative